StockNews.AISignal intelligence

Public signal · 1-minute delayed

Signal brief

Source-backed market context you can read and share without an account.

RVMDBullishAnalyst Target Updateanalyst
High materiality7/10

Revolution Medicines price target raised to $275 from $240 at Needham

Aug 31, 2026, 3:01 PM EDT1 sourcesAI-analyzed
Why it may matterVerify against the original reporting

bullish

AI summary

What happened, with direct paths to the underlying reporting

Needham raises RVMD target to $275; price $207.88.

  • RVMD target $275; price $207.88; Needham.

Key facts

  1. 01

    Target: $275

  2. 02

    Posted price: $207.88

  3. 03

    Analyst firm: Needham

How to read this signal

Transparent limits for an AI-generated research aid

StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.